ONGC reports highest ever net profit by any corporate at Rs 18,347 cr in Q2, BFSI News, ET BFSI

[ad_1]

Read More/Less


New Delhi, Nov 12 (PTI) State-owned Oil and Natural Gas Corporation (ONGC) on Friday reported the highest ever quarterly net profit by any Indian firm of over Rs 18,347 crore as it made a one-time tax gain on opting for a lower rate regime. Net profit in July-September period at Rs 18,347.73 crore is compared with Rs 2,757.77 crore net profit in the same period a year back, according to the company’s filing to the stock exchanges.

The profit in the quarter is compared with Rs 11,246.44 crore net profit ONGC had earned in full 2020-21 fiscal year (April 2020 to March 2021).

This is the highest ever quarterly net profit by any company in the country.

Prior to this, Indian Oil Corporation (IOC) held the distinction of posting the highest ever quarterly profit when it reported a net earning of Rs 14,512.81 crore in January-March 2013.

IOC’s net profit in the fourth quarter of 2012-13 fiscal was abnormally high because of receipt of fuel subsidy for the full year in one quarter. Its annual profit that fiscal was Rs 5,005.17 crore as it had posted losses in the previous quarter on failing to get fuel subsidy support.

ONGC, in the first half (April-September) of the current fiscal earned Rs 22,682.48 crore net profit as against Rs 3,254.35 crore a year back.

The profit in the second quarter (July-September) was aided by higher oil prices and the one-time tax gain of Rs 8,541 crore.

ONGC said the company has an option to pay corporate income tax at the rate of 22 per cent plus applicable surcharge and cess (lower rate) as against the earlier rate of 30 per cent plus applicable surcharge and cess, subject to certain conditions.

“Considering all the provisions under said section 115BAA of the Income Tax Act, 1961, during the quarter the company has decided to avail the option of lower rate with effect from the financial year 2020-21.

“Accordingly, the company has recognized provision for tax expenses in the financial results for the quarter and half year ended September 30, 2021, and re-measured its net Deferred Tax liabilities on the basis of the provision prescribed in the said section,” it said.

The net impact due to availing of the option has resulted in a decrease in deferred tax by Rs 8,541 crore and a decrease in current tax by Rs 1,304 crore (including relating to earlier years).

Also aiding the profit was a surge in oil prices, it added.

ONGC got USD 69.36 for every barrel of crude oil it produced from fields under its operation as against USD 41.38 per barrel realisation in July-September 2020.

Revenue soared 44 per cent to Rs 24,353 crore.

The higher price offset lower production.

ONGC produced almost 4 per cent less crude oil at 5.471 million tonne while gas output fell 7 per cent to 5.467 billion cubic meters.

“The production of crude oil and gas has declined during current year mainly due to restrictive conditions created by cyclone Tauktae and due to Covid impact,” the firm later said in a press statement.

Also, delay in mobilization of mobile processing unit to WO-16 Cluster project in the western offshore also impacted production from this field. The board approved interim dividend of 110 per cent (Rs 5.50 on each equity share of Rs 5). Total payout on this account will be Rs 6,919 crore.



[ad_2]

CLICK HERE TO APPLY

Buy This Large Cap Stock For A Return of 45.3% In 1 Year Says Kotak Securities

[ad_1]

Read More/Less


Q2 FY’22 results of the company

In the second quarter of FY’22, SAIL reported a consolidated net profit of Rs 4339 crore. According to SAIL’s performance in Q2 FY’22, Crude Steel Production totaled 4.468 million tonnes, Saleable Steel Sales remained 4.280 million tonnes, and Gross Borrowings were Rs 22,478 crore as of 30 September 2021, down from Rs 35,350 crore as of 31 March 2021, a reduction of Rs 12,872 crore during H1 FY’22. The company’s board of directors has declared an interim dividend of Rs 4 per share to shareholders for FY’22.

Date: 29.10.2021 Standalone In Rs (Cr) In Rs (Cr) In Rs (Cr) Consolidated In Rs (Cr) In Rs (Cr) In Rs (Cr)
Q1 FY’22 Q2 FY’22 H1 FY’22 H1 FY’21 Q1 FY’22 Q2 FY’22 H1 FY’22 H1 FY’21
Revenue from Operations 20642 26827 47469 25991 20643 26828 47471 25993
EBITDA 6674 7248 13921 1973 6741 7290 14031 2078
PBT 5145 5753 10898 -1374 5212 5795 11007 -1270
PAT 3850 4304 8154 -877 3897 4339 8236 -790
Source: sail.co.in

Buy Steel Authority of India (SAIL) with a target price of Rs 170 says Kotak Securities

Buy Steel Authority of India (SAIL) with a target price of Rs 170 says Kotak Securities

Kotak Securities has said “SAIL’s EBITDA/ton increased 18% QoQ to a record high of Rs19,728/ton on higher steel prices. SAIL’s expansion projects are at the last stage of completion, we conservatively build +7% YoY volume in FY22E versus guidance of 11%. We expect SAIL’s EBITDA to grow at 10% CAGR over FY21-24E.”

The brokerage has claimed in its research report that “SAIL reduced net debt by Rs4200 cr in 1QFY22, aided by strong operational cash flows and measured CAPEX. We estimate net debt to reduce further to Rs19500 cr as of FY22E, aided by strong margins. We estimate that SAIL’s future growth CAPEX would be funded by Operating Cash Flow assuming mid-cycle margins from FY2023E and net debt/EBITDA to remain below 1X.”

Disclaimer

Disclaimer

This stock is picked from the brokerage report of Kotak Securities. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution. Greynium Information Technologies, the author, and the brokerage house are not liable for any losses caused as a result of decisions based on the article.



[ad_2]

CLICK HERE TO APPLY

5 Best Fixed Deposits To Invest For 3 To 5 Years In 2021

[ad_1]

Read More/Less


Investment

oi-Vipul Das

|

Investing in fixed deposits under the debt category, whether you are a non-senior or senior citizen, is essential to have in your portfolio when it comes to a regular flow of income with a fixed rate of return throughout the chosen maturity period. Fixed deposits, in addition to fixed interest rates, allow you to invest for a maturity term ranging from 7 days to 10 years, allowing you to meet a variety of investment objectives. Fixed deposits, on the other hand, provide a blend of capital safety and capital appreciation, since your deposits up to Rs 5 lakhs are insured by the DICGC. Despite the fact that fixed deposit interest rates have been dropping since many banks lowered their interest rates following the Reserve Bank of India’s decision to maintain the repo rate constant at 4%, here are the banks that are still offering a decent return on fixed deposits of less than Rs 2 Cr maturing in 3 to less than 5 years.

Top 5 Public Sector Banks Promising Good Returns On 3 to 5 Year FDs

Top 5 Public Sector Banks Promising Good Returns On 3 to 5 Year FDs

Based on our own research, here are the top 5 public sector banks that are offering the highest interest rates on 3 to 5 years of fixed deposits.

Banks Regular Interest Rates Interest rates for senior citizens W.e.f.
Union Bank of India 5.40% 5.90% 01/09/2021
State Bank of India 5.30% 5.80% 08.01.2021
Punjab & Sind Bank 5.30% 5.80% 16/09/2021
Punjab National Bank 5.25% 5.75% 01.08.2021
Indian Overseas Bank 5.25% 5.75% 09.11.2020
Source: Bank Website

Top 5 Private Sector Banks Offering Best Returns On 3 to 5 Year FDs

Top 5 Private Sector Banks Offering Best Returns On 3 to 5 Year FDs

Here are the top 5 private sector banks that are currently offering pretty good interest rates on deposits maturing in 3 years to less than 5 years.

Banks Regular Interest Rates Interest rates for senior citizens W.e.f.
RBL Bank 6.30% 6.80% September 01, 2021
Yes Bank 6.25% 7.00% 3rd November 2021
IndusInd Bank 6.00% 6.50% July 23rd, 2021
DCB Bank 5.95% 6.45% 17th August 2021
Axis Bank 5.40% 6.05% 10/11/2021
Source: Bank Website

Top 5 Small Finance Banks Providing Highest Interest Rates On FDs of 3 to 5 Years

Top 5 Small Finance Banks Providing Highest Interest Rates On FDs of 3 to 5 Years

On deposits of less than Rs 2 Cr maturing in 3 to 5 years, here are the top 5 small finance banks that are currently promising decent returns to both non-senior and senior citizens.

Banks Regular Interest Rates Interest rates for senior citizens W.e.f.
Jana Small Finance Bank 6.75% 7.25% 07/05/2021
Suryoday Small Finance Bank 6.50% to 6.75% 6.50% to 7.00% September 09, 2021
North East Small Finance Bank 6.50% 7.00% 19th April 2021
Fincare Small Finance Bank 6.50% to 6.25% 7.00% to 6.75% 25th October 2021
Ujjivan Small Finance Bank 6.25% 6.75% 16th August 2021
Source: Bank Website

Story first published: Saturday, November 13, 2021, 12:17 [IST]



[ad_2]

CLICK HERE TO APPLY

Dr. K.V. Subramanian, BFSI News, ET BFSI

[ad_1]

Read More/Less


India should focus on supply through reforms & capital expenditure to create assets in the economy, said Dr. K.V. Subramanian, Chief Economic Adviser, Government of India.

He was speaking about the three decades of 1991 economic reforms at the 3rd Global Finance Conclave organised by the Jindal School of Banking & Finance (JSBF) today.

Elaborating on how the economy has grown since 1991, Dr. Subramanian pointed out how the country handled the demand and supply line impact during the COVID-19 crisis. “Recognising that the COVID pandemic requires social distancing and lockdowns, it was obvious that not only would there be a demand side impact, but disruptions of the supply line chains too. While demand can actually be pushed up faster, it takes at least eight to 10 months for supply to increase. What India has done during this crisis, and I hope this will become an important macro-economic template that other countries and policymakers should study in terms of the policy response, is that India actually focused on the supply side – whether it is through the reforms or the capital expenditure. He added, “If you have an aggregate supply line not changing – you only have increasing demand. In macroeconomic terms, it means there will be a path to growth but inflation will go up as well. When inflation goes up, monetary policy has to try and unwind that demand. What you have then is the increase in demand that the fiscal policy did and the monetary policy tries to unwind it. So, you come back to square one, that push to growth that you got is a temporary one because monetary policy and fiscal policy work at cross purposes.”

The theme for the conclave is “India’s Growth Story from 1991 To 2021, And Beyond” to commemorate 30 years of the transformative 1991 reforms and to understand the challenges that need to be addressed as we slowly come out of a pandemic.

The Presidential address was by Dr. Shankar Acharya, Former Chief Economic Adviser and author of An Economist at Home and Abroad.”The once-in-century pandemic has had a major impact on the Indian economy. All indices like the GDP, unemployment, female participation in the labour force, fiscal deficit and debt were impacted. Lockdowns became a common policy during this time. This led to income/consumption losses creating a high vulnerability among the poorer sections of India. There will, however, be economic recovery even though there is still a high level of uncertainty due to the pandemic. The biggest impact has been on anon-agricultural informal sector. There have been significant policy initiatives over the last two years and they are a step in the right direction. If the effects of Covid-19 and other constraints on our medium term growth performance outweigh the reform intention, then it may lead to a period of modest growth over the next five years.”

Professor (Dr.) C. Raj Kumar, Founding Vice-Chancellor of O.P. Jindal Global University (JGU) in his inaugural address said, “The 1991 economic reforms created a new vision for India which not only impacted the economic sector and the society at large but it also created new opportunities for institution building. The idea of private higher education institutions with a view to improve the quality of education and promoting excellence is an outcome of the idea whose time had come. The reality was that though India has historically contributed to knowledge society globally, the contemporary evolution of Indian education at the dawn of Independence was limited. We only had 20 universities and today we have over 1000 universities and over 50,000 colleges. We strongly believe that there are critical elements to improving the quality of governance to improve higher education. This includes commitment to internationalization, advancing research, interdisciplinary learning, high quality faculty and equitable access to education for all. The economic reforms of 1991 that were ushered in the country led to other forms of reforms that further shaped the socio-economic future of India. Today, the National Education Policy 2020 has enormous implications with the potential of reimagining the future of Indian universities, creating an intellectual, political and social consciousness and political impetus for the improvement of higher education.”

Notable addresses were delivered by Dr. Amar Patnaik, and Dr Sasmit Patra, Members of Parliament, Rajya Sabha. Other eminent speakers at the Conclave include Ajit Pai, Distinguished Expert, Economic & Finance, Niti Aayog, Dr. Ashok K. Lahiri, Former Chief Economic Adviser, Government of India and Dr. PTR Palanivel Thiagarajan, Minister for Finance and Human Resources Management, Government of Tamil Nadu and Dr. Mukulita Vijayawargiya, Whole-Time Member of the Insolvency and Bankruptcy Board of India (IBBI).

The Global Finance Conclave will host 55 speakers including the current Chief Economic Advisor to the Government of India, 2 former Chief Economic Advisors and noted economists, 1 Minister of Finance and Human Resource Management (TN), 2 Members of Parliament (Rajya Sabha), 3 Members of State Legislative Assemblies, 1 Senior Expert from the NITI Aayog along with academics, economists, bankers and lawyers.

Dr. Ashish Bhardwaj, Professor & Dean, Jindal School of Business and Finance said, “The reforms of the 1990s changed the grammar of our country and the confidence of our people forever. Since the historic developments that happened 30 years, there is a need to reflect on the implications of India’s growth story from 1991 to 2021 and beyond. Understanding where we came from and how we emerged, will help us understand where to go from here and how to get there. Answers to these tough questions will emerge from deliberations in the Conclave. To a large extent, the fate of the world will depend on what India decides to do, how fast we do it, and how quickly we learn the lessons of the past.”

This story is provided by OP Jindal University. will not be responsible in any way for the content of this article.



[ad_2]

CLICK HERE TO APPLY

ICICI Direct Suggest To Buy This Auto Ancillary Stock For 23% Gains In A Year

[ad_1]

Read More/Less


Balkrishna Industries:

ICICI Direct has put its bet on this tyre and tubes company- Balkrishna Industries and has set a target of Rs. 2900 to be realized in 1-year. The stock last closed at a price of Rs. 2361.75, which means an upside of close to 23 percent.

About the stock: The company is a leading player in the niche tyre industry that find application in heavy machinery for agriculture as well as mining areas. The company draws major portion of its revenue i.e. as much as 80 percent from exports.

Talking about the different channels, replacement shall account for 70 percent while OEM share is at 26 percent. Agriculture accounts for 64% of volumes. Further the company has been a consistent performer with an over 20 percent margins and return ratios.

Q2Fy22 earnings of Balkrishna Industries

Q2Fy22 earnings of Balkrishna Industries

Net sales for the September ended quarter was at Rs. 2050 crore, up 13.1 per cent sequentially. EBIDTA margin declined. PAT grew 14 percent to Rs. 377 crore owing to higher additional income.

Advice on Balkrishna Industries stock by ICICI Direct

The company over the 5-year period has outperformed Nifty Auto index. “We retain BUY on Balkrishna amid robust demand prospects, healthy financials and

value the scrip at revised target price of Rs. 2,900 i.e. 32x

P/E on FY23-24E average EPS of Rs. 90.6 (earlier target price Rs. 2,825).

Key triggers for future price performance:

Key triggers for future price performance:

-The company’s aggressive plans to double its market share to 10 percent.

– There is seen robust demand across segments including agriculture, OTR for propelling volume growth.

– There is in place backward integration as well as aggressive brownfield expansion.

-Net debt free b/s, double-digit return ratios & strong cash generation

-Sales, PAT growth seen at a CAGR of 21.9%, 17.1% over FY21-24E

Alternate Stock Idea: The company in the auto ancillary space likes JK Tyre.

• Walking the talk on b/s deleveraging, sweating of assets & capital efficiency

• BUY with a target price of | 185

GoodReturns.in

Disclaimer:

Disclaimer:

This stock is picked from the brokerage report of ICICI Direct. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution. Greynium Information Technologies, the author, and the brokerage house are not liable for any losses caused as a result of decisions based on the article.



[ad_2]

CLICK HERE TO APPLY

This Healthcare Stock Has A “BUY” Call From Edelweiss With A Target Price of Rs 3,753

[ad_1]

Read More/Less


Q2FY22 results of Metropolis Healthcare Ltd

According to the brokerage “Metropolis Healthcare (METROHL) reported marginally miss in our estimates. Revenue grew by 5% YoY to INR 303cr, ~4% lower than our estimates. EBITDA reported INR 90cr (down ~1% YoY & ~4.5% below our estimates) and EBITDA margin of 29.8% contracted 170bps YoY vs our estimates of 30%.”

Edelweiss has said “METROHL reported non-COVID revenue of INR 260cr (up ~38% YoY and down 2% QoQ) Vs 33%/22% YoY growth for Dr Lal/Vijaya, on account of unlocking of economy and easing of covid19 restrictions. METROHL’s Q2FY22 Non-COVID realization per test/patient (up 7%/12% YoY), Non-COVID patient volume up 23% YoY and test volume up 28.6% YoY.”

Based on the research report of the brokerage the company’s “EBITDA margin contracted by 170bps YoY to 29.8% (v/s est. 30% and 28.4% of Dr Lal) and excluding CSR & ESOP expenses EBITDA margin was 30.8%. PAT reported INR 58cr (down ~3% YoY) against our estimates of INR 61cr.”

Edelweiss has clarified “METROHL’s COVID revenue down by 57% YoY to INR 43cr with the reduction in COVID cases. METROHL’s Q2FY22 Non-COVID realization per test/patient (up 7%/12% YoY), Non-COVID patient volume up 23% YoY and test volume up 28.6% YoY. Revenue contribution from specialised tests (non-covid) increased to 43% in Q2FY22 from 39% in Q2FY21. The share of B2C business (non-Covid revenue) in focus cities stood at 60% in Q2FY22, which management aims to increase to 65% in the coming years.”

Buy Metropolis Healthcare Ltd with a target price of Rs 3,753

Buy Metropolis Healthcare Ltd with a target price of Rs 3,753

Edelweiss has reported that “The company has reported results marginally lower than our estimates while non-COVID business in H1FY22 has come back strongly, revenue up 80% YoY against 54% for Dr Lal and EBITDA margin also maintained at ~30% indicates METROHL’s premium business model and dominant market share in major geographies (where it is present). The strong expansion plans along with Hitech acquisition would be healthy growth drivers for the company in the coming years. However, entry of Dr Lal through Suburban in Mumbai market would create some challenges for the company.”

The brokerage has claimed that “We have consolidated Hitech numbers in our estimates, thus, we have revised our earnings estimate upwards for FY23E by 19%, and also introduced FY24 estimates. The stock is currently trading at 62x/49x/44x FY22E/FY23E/FY24E earnings. Maintain ‘BUY’ with a revised target price of INR 3753 (earlier INR3,356) (DCF-based).”

Disclaimer

Disclaimer

The above stock is picked from the brokerage report of Edelweiss Broking Ltd. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution. Greynium Information Technologies, the author, and the brokerage house are not liable for any losses caused as a result of decisions based on the article.



[ad_2]

CLICK HERE TO APPLY

2 Balanced Funds For SIPs Rated No 1 By Crisil

[ad_1]

Read More/Less


Kotak Debt Hybrid Fund

This fund has been rated No 1 by Crisil in the conservative hybrid category. The fund has generated a returns of 19% in the last 1-year and the 3-year returns are 13.89% on an annualized basis.

At the moment the fund has around 56% in debt, about 23% in equities and the remaining in cash and cash equivalents. A bulk of the investment is in government securities. The assets under management are to the tune of around Rs 1,160 crores.

The minimum amount required to invest by way of SIPs is Rs 1,000. With the Sensex at around the 60,000 points level mark and with most analysts believing that the markets are over valued, moving money to conservative balanced fund SIPs may not be a bad idea. There are many investors who may have made decent money over the last 1-year or so. Kotak Debt Hybrid Fund has also been rated 5-star by Value Research.

Canara Robeco Conservative Hybrid Fund

Canara Robeco Conservative Hybrid Fund

This fund too like the Kotak Debt Hybrid Fund has been rated No 1 by CRISIL. The Canara Robeco Conservative Hybrid Fund seeks to generate to income through investment primarily in debt securities with marginal exposures in equity and money market instruments of various maturities and risk profile.

The fund has given a returns of 13.61% in the last 1-year, while the 3-year returns are close to 12.46% on an annualized basis. The assets under management are to the tune of around Rs 1,000 crores.

Investors can start an SIP with a sum of Rs 1,000 every month. The fund has also been rated 5-star by Value Research, apart from CRISIL.

Disclaimer

Disclaimer

Investors are advised caution as investing in mutual funds is risky. The report is for informational purposes and Greynium Information Technologies, the author and the brokerage would not be responsible for any losses incurred by investors based on the report above.



[ad_2]

CLICK HERE TO APPLY

2 Stocks To Buy Suggested By Edelweiss Broking Ltd For 36% Returns

[ad_1]

Read More/Less


Q2FY22 results of CreditAccess Grameen Ltd

According to Edelweiss “CreditAccess Grameen’s (CAG) reported numbers largely in-line with our estimates on the net revenues front. Higher OPEX due to branch expansion was offset by lower than expected provisions resulting in a PAT beat of 10% against our estimates. Disbursements came in above pre-covid quarterly run rate but remain below Q3/Q4FY21 levels. Oct’21 disbursements came in higher than July-Sept’21 monthly run-rate indicating strong growth momentum in H2Y22. Gross Loan Portfolio (GLP) grew by 19% YoY / 5% QoQ to INR 13,333cr driven by robust disbursements. Management has guided for a 17-19% growth in GLP for FY22 sans a covid third wave.”

Edelweiss has said in its research report that the company’s “Consolidated GS-3 remained largely steady with marginal increase of 11bps sequentially to 7.7% largely driven by MMFL Stage -3 recognition being moved to 60dpd+ from 90dpd+ in the quarter. CAG carries an overall ECL provision of INR 740cr (5.9% of loan book). Consol. restructured assets stood at ~1.3% of GLP well ahead of other MFI focused banks and NBFCMFIs which have reported results till date. Management expects credit costs to remain between 4.7-4.9% for FY22 as the company would write-off sticky stage -3 assets in H2FY22.”

Buy CreditAccess Grameen Ltd with a target price of Rs 816

Buy CreditAccess Grameen Ltd with a target price of Rs 816

The brokerage has said that “CAG has reported both growth and asset quality better than its peers and has emerged out of the pandemic in a much better position compared to peers. Incremental provisioning in H2FY22 is likely to provide a clean slate to the company to pursue growth and pre-Covid return ratios in FY23. We believe CAG is best placed to capture the structural MFI growth story with a covid third wave being the significant risk to our hypothesis. We maintain ‘BUY’ with the same target price of INR816.”

Q2FY22 results of Krishna Institute of Medical Sciences Ltd

Q2FY22 results of Krishna Institute of Medical Sciences Ltd

According to Edelweiss “KIMS’ reported a decent set of numbers with Revenue (INR 412cr up 1% YoY) miss our estimates by ~3%, however, EBITDA/PAT reported ahead of our estimates by 2%/10% to INR129cr/INR84cr. KIMS saw normalization of business as COVID-related cases came down and elective surgeries picked up. Increased Patient flow, new doctor additions in existing specialties, consistent growth in Heart and Lung transplant programme & increasing normalization of business to pre-COVID levels resulted in flat revenue.”

The company’s “Gross profit grew 4% YoY & down 10% QoQ to INR 326cr in Q2FY22 with gross margin expanded by 280bps YoY to 79.2%. EBITDA margin came in at a record level of 31.3% (v/s est. of 29.7%), mainly on account of tighter control on medical consumption cost, high occupancy and robust IP/OP volume. The acquired asset reported significant improvement in EBITDA margin to 20.7% in H1FY22 (vs 16.8% in FY21)” says Edelweiss.

Buy Krishna Institute of Medical Sciences Ltd with a target price of Rs 1,651

Buy Krishna Institute of Medical Sciences Ltd with a target price of Rs 1,651

Edelweiss has claimed in its research report that “KIMS reported good improvement in non-COVID business in Q2FY22. We maintain our positive view on KIMS, on account of robust growth in non-COVID volume & improvement in occupancy, maintained higher margins with a sustained focus on operational efficiency and strong expansion plans. The net cash at the end of the quarter stood at INR 395cr (gross debt of INR 50cr). KIMS expected to pay INR 230cr (first tranche of acquisition cost) for Sunshine Hospitals acquisition in the near term, even after that company has net cash. KIMS’s strong expansion plan for the addition of ~2,300 beds over 36-48 months will be funded through a mix of internal accrual and borrowing, with maintaining D/E at a restricted level. Maintain ‘BUY’ with a target price of INR1,651/share.”

Disclaimer

Disclaimer

The above stocks are picked from the brokerage report of Edelweiss Broking Ltd. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution. Greynium Information Technologies, the author, and the brokerage house are not liable for any losses caused as a result of decisions based on the article.



[ad_2]

CLICK HERE TO APPLY

2 Bank Stocks To Buy For Gains Up To 30% In 1-Year

[ad_1]

Read More/Less


Buy, Bank of Baroda stock

Current market price Rs 101.35
Target price Rs 130
Gains 28.27%

According to Emkay Global, despite lower growth/NIM, Bank of Baroda reported a strong beat on net profit at Rs 21 billion (est. Rs 10 billion), mainly aided by higher other income, DHFL recovery of Rs 8.8 billion and contained provisions.

“The gross non performing assets ratio improved by 76 bps qoq to 8.1%, while the standard net restructured book rose marginally to 3% of loans (2.9% in Q1),” the brokerage has said.

Better growth in H2 to support NIM uptick for Bank of Baroda

Better growth in H2 to support NIM uptick for Bank of Baroda

According to Emkay global, overall credit growth was moderate for Bank of Baroda at 4% yoy to Rs6.9bn due to corporate drag and sub-par retail growth.

“Within retail, mortgage growth was relatively slower, while PL was up 33% yoy and auto was up 23% yoy. Growth in gold loans was also strong at 147% yoy, albeit on a low base. According to management, corporate is seeing a pickup in Q3 with decent brownfield and working capital expansion proposals in the pipeline. The domestic CASA ratio improved slightly to 43.5%. However, slower growth and interest reversals led to a 19bps qoq compression in NIM to 2.9%. Going forward, the bank plans to improve growth/LDR, which, coupled with better traction in retail and lower interest reversals, should improve NIMs,” the brokerage has said.

Valuations and outlook for Bank of Baroda

Valuations and outlook for Bank of Baroda

Bank of Baroda remains well-capitalised with Standalone Bank CET 1 of 11.4% and easing asset quality stress, which is expected to accelerate growth, according to Emkay Global.

“This should drive up margins, which, coupled with lower LLP, should lead to gradual improvement in its RoE trajectory to 10-12% over FY23-24E from a low of 1% in FY21. Retain Buy with a revised target price of Rs 130, based on 0.8x Dec’23E ABV,” the brokerage has said.

Buy Karur Vysya Bank stock

Buy Karur Vysya Bank stock

Current market price Rs 59.95
Target price Rs 72
Gains 20.10%

The brokerage also has a buy call on the stock of Karur Vysya Bank.

“KVB reported a strong net profit beat (Rs 1.6bn vs. estimate of Rs 1 bn), mainly on better margins, lower opex (despite providing for family pension) and contained provisions.

Asset-quality performance was mixed. The GNPA ratio was down 59 bps qoq to 7.4%, but

the restructured pool inched up 120 bps to 3.2% of loans – which is reasonable vs. Peers,” the brokerage has said.

“We maintain our Buy rating with a revised Dec’22 target price of Rs72 (Rs 62 earlier), valuing the bank at 0.7x Dec’23E ABV, factoring in a better liability and capital profile; good/reasonable asset-quality performance in the current challenging times vs. peers; and an expected steady improvement in return ratios,” the brokerage has said.



[ad_2]

CLICK HERE TO APPLY

4 Stocks To Buy From The Engineering, Capital Goods And Infra Space

[ad_1]

Read More/Less


Tendering Activity Sees 12% YoY Growth, Year To Date

Delivering buoyant growth, tendering activity for Year To Date FY22 has now surpassed the levels achieved in the last three years (Year To Date FY19/20/21), led by healthy growth in Roads, Power Distribution and Water Supply. Railways, Real Estate and Irrigation are yet to gain pre-Covid momentum, an Emkay Global report has said.

For Year To Date FY22, overall tendering has achieved 12% yoy growth and a 35% 2-year CAGR. Oct’21 tenders saw healthy growth in Roads, Railways, Irrigation and Mining. Recently, a request for Proposal (RFP) for a Rs 181 bn project (20% of Oct’21 tenders) for Advanced Chemistry Cell (ACC) (under PLI) was released.

Stocks picks from the engineering, capital goods and infra space

Stocks picks from the engineering, capital goods and infra space

Emkay Global’s top picks in the sector are L&T (target price Rs2,200), KPTL (target price Rs 555), HG Infra (target price Rs 800), and KEC (target price Rs 530), considering their superior execution capabilities, existing order backlog, and relative valuations.

“Siemens (Under Review) and JMC Projects (Not Rated) saw strong order inflows. Siemens had an inflow of Rs 43bn (Jun’21) vs. the Rs 30 bn run rate, increasing the order book to an all-time high of Rs143 bn as of June’21. JMC received Rs79.5 bn in inflows during H1FY22, up 43% YoY, leading to a peak order book of Rs 187 bn,” the brokerage has said.

Awarding activity

Awarding activity

“Although YTDFY22 awarding activity has crossed YTDFY20/21 levels, delivering 10% yoy and a 20% 2-year CAGR, it still remains 40% below FY19 levels (Rs700bn).

Growth continues to be driven by Roads, Water Supply and Power Equipment. Despite some lag in awarding activity, a solid pipeline of investments and the economic recovery make us optimistic about a rebound in awards in the upcoming months,” Emkay Global has said in its report.

According to the report, excluding roads, the 2-year CAGR dropped to 7%, clearly highlighting traction in building the country’s road network, underpinned by the government’s focus on accelerating infrastructure-led growth.

“Large awards are characterized by projects in Roads, Water Supply and Mining. The recently notified amended minerals concession rules regarding the sale and transfer of mines may provide impetus to the mining industry,” the brokerage has said.

Disclaimer

Disclaimer

The above stocks are picked from the brokerage report of Emkay Global. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution. Greynium Information Technologies, the author, and the brokerage house are not liable for any losses caused as a result of decisions based on the article.



[ad_2]

CLICK HERE TO APPLY

1 31 32 33 34 35 387